PRTA Q4 2019 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$256,000+32.0% YoY

Gross Profit

-$15M-5943.4% margin

Operating Income

-$23M-9091.4% margin

Net Income

-$22M-8419.5% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

+24.9%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$419M

Total Liabilities

$146M

Stockholders' Equity

$273M

Cash & Equivalents

$376M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$256,000	$194,000	+32.0%
Gross Profit	-$15M	-$16M	+6.7%
Operating Income	-$23M	-$23M	-2.3%
Net Income	-$22M	-$22M	+4.0%